Authors: SARABANCHONG V REINUS J CLAIN DJ AYTAMAN A LEVENDOGLU H BLOOM AA DELARIVA E SPINNELL M PUPPO MD MCMAHON DJ GARCIACARRASQUILLO RJ MAGUN AM WORMAN HJ

Citation: V. Sarabanchong et al., DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INTERFERON-ALPHA-2B PLUS RIBAVIRIN VERSUS INTERFERON-ALPHA-2B FOR RETREATMENT OF PATIENTS WITH CHRONIC HEPATITIS-C WHO FAILED PREVIOUS TREATMENT WITH INTERFERON-ALPHA, Hepatology, 28(4), 1998, pp. 2163-2163

Authors: LEFKOWITCH JH YEE HT SWEETING J GREEN PHR MAGUN AM

Citation: Jh. Lefkowitch et al., IRON-RICH FOCI IN CHRONIC VIRAL-HEPATITIS, Human pathology, 29(2), 1998, pp. 116-118

Authors: DELARIVA E PUPPO MD FACTOR SH SARABANCHONG V LIGRESTI RJ FINEGOLD J RILEY TH GARCIACARRASQUILLO RJ MARKOWITZ DD MAGUN AM WORMAN HJ

Citation: E. Delariva et al., EFFECTS OF INCREASING INTERFERON-ALPHA-2B DOSE IN PATIENTS WITH CHRONIC HEPATITIS-C NOT RESPONDING TO 3 MILLION UNITS 3 TIMES A WEEK, Hepatology, 26(4), 1997, pp. 1154-1154

Authors: ARORA RR MAGUN AM GROSSMAN M KATZ J

Citation: Rr. Arora et al., CHOLESTEROL EMBOLIZATION SYNDROME AFTER INTRAVENOUS TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION, The American heart journal, 126(1), 1993, pp. 225-228